Ipsen S.A. - IPN.PA

IPN.PA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IPN.PA	0.3	0.2	5.4	5.4	15.8	12.8	33.2	79.1	170.0	403.0
S&P 500	-0.5	1.2	2.9	5.4	10.9	23.1	32.9	85.9	198.9	34104.6

Compare IPN.PA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IPN.PA
name	Ipsen S.A.
price	119.2
changes percentage	0.3367
change	0.4
day low	119.2
day high	120.1
year high	126.7
year low	99.7
market cap	9850594428
price avg 50	113.71
price avg 200	112.7775
exchange	EURONEXT
volume	59064
avg volume	65278
open	119.6
previous close	118.8
eps	7.95
pe	14.99
earnings announcement	2025-02-13T06:00:00.000+0000
shares outstanding	82639215
timestamp	2025-01-31 16:35:24

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 35.3%

Overall Quarterly Financial Health: 40.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	3306400000	3156400000	4.75
gross profit	2735200000	2628700000	4.05
gross profit ratio	0.83	0.83	-0.67
research and development expenses	619300000	445300000	39.07
operating expenses	1919200000	1905799999	0.70
interest income	0	5300000	-100.00
interest expense	19400000	23800000	-18.49
ebitda	1143000000	1130900000	1.07
ebitdaratio	0.35	0.36	-3.52
operating income	816000000	943700000	-13.53
operating income ratio	0.25	0.3	-17.45
net income	644400000	648600000	-0.65
net income ratio	0.19	0.21	-5.15
eps	7.79	7.2	8.19

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3,306 million in 2023 from 3,156 million in 2022 representing a change of 4.75%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,735 million in 2023 from 2,629 million in 2022 representing a change of 4.05%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 619 million in 2023 from 445 million in 2022 representing a change of 39.07%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,143 million in 2023 from 1,131 million in 2022 representing a change of 1.07%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 7.79 in 2023 from 7.79 in 2022 representing a change of 8.19%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 1,919 million in 2023 from 1,906 million in 2022 representing a change of 0.7%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 816 million in 2023 from 944 million in 2022 representing a change of -13.53%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 644 million in 2023 from 649 million in 2022 representing a change of -0.65%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	1751800000	1590900000	10.11
gross profit	1435100000	1289600000	11.28
gross profit ratio	0.82	0.81	1.06
research and development expenses	323400000	329100000	-1.73
operating expenses	1117300000	818900000	36.44
interest income	5600000	3800000	47.37
interest expense	10900000	11200000	-2.68
ebitda	481700000	631300000	-23.70
ebitdaratio	0.27	0.4	-30.71
operating income	317800000	470700000	-32.48
operating income ratio	0.18	0.3	-38.68
net income	232000000	449200000	-48.35
net income ratio	0.13	0.28	-53.10
eps	2.9	5.44	-46.69

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,752 million in 2024Q2 from 1,591 million in 2023Q4 representing a change of 10.11%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,435 million in 2024Q2 from 1,290 million in 2023Q4 representing a change of 11.28%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 1,117 million in 2024Q2 from 819 million in 2023Q4 representing a change of 36.44%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 323 million in 2024Q2 from 329 million in 2023Q4 representing a change of -1.73%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 482 million in 2024Q2 from 631 million in 2023Q4 representing a change of -23.7%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 318 million in 2024Q2 from 471 million in 2023Q4 representing a change of -32.48%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 232 million in 2024Q2 from 449 million in 2023Q4 representing a change of -48.35%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.9 in 2024Q2 from 2.9 in 2023Q4 representing a change of -46.69%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	6322900000	5607900000	12.75
total liabilities	2499100000	2271200000	10.03
total equity	3823800000	3336700000	14.60
cash and cash equivalents	528400000	1169300000	-54.81
short term investments	0	31000000	-100.00
long term investments	131699999	136300000	-3.37
total current assets	1898400000	2397600000	-20.82
total non current assets	4424500000	3210299999	37.82
total current liabilities	1626800000	1335400000	21.82
total non current liabilities	872300000	935799999	-6.79
common stock	83800000	83800000	0.00
retained earnings	644400000	648600000	-0.65
total debt	306100000	771600000	-60.33

Overall Score of Annual Balance Sheet

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,323 million in 2023 from 5,608 million in 2022 representing a change of 12.75%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 3,824 million in 2023 from 3,337 million in 2022 representing a change of 14.6%. This indicates an increase in shareholders' equity.

  Total Debt: Total Debt decreased to 306 million in 2023 from 772 million in 2022 representing a change of -60.33%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 2,499 million in 2023 from 2,271 million in 2022 representing a change of 10.03%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 528 million in 2023 from 1,169 million in 2022 representing a change of -54.81%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 31 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,898 million in 2023 from 2,398 million in 2022 representing a change of -20.82%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 1,627 million in 2023 from 1,335 million in 2022 representing a change of 21.82%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 644 million in 2023 from 649 million in 2022 representing a change of -0.65%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	6547200000	6322900000	3.55
total liabilities	2501100000	2499000000	0.08
total equity	4046100000	3823800000	5.81
cash and cash equivalents	485400000	528400000	-8.14
short term investments	0	10600000	-100.00
long term investments	141400000	131699999	7.37
total current assets	1899800000	1898400000	0.07
total non current assets	4647400000	4424500000	5.04
total current liabilities	1665200000	1626800000	2.36
total non current liabilities	835900000	872200000	-4.16
common stock	83800000	83800000	0.00
retained earnings	232000000	644400000	-64.00
total debt	490200000	475500000	3.09

Overall Score of Quarterly Balance Sheet

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,547 million in 2024Q2 from 6,323 million in 2023Q4 representing a change of 3.55%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 4,046 million in 2024Q2 from 3,824 million in 2023Q4 representing a change of 5.81%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 1,900 million in 2024Q2 from 1,898 million in 2023Q4 representing a change of 0.07%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 2,501 million in 2024Q2 from 2,499 million in 2023Q4 representing a change of 0.08%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 485 million in 2024Q2 from 528 million in 2023Q4 representing a change of -8.14%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q2 from 11 million in 2023Q4 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 1,665 million in 2024Q2 from 1,627 million in 2023Q4 representing a change of 2.36%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 232 million in 2024Q2 from 644 million in 2023Q4 representing a change of -64.0%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 490 million in 2024Q2 from 476 million in 2023Q4 representing a change of 3.09%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-646000000	354600000	-282.18
operating cash flow	865900000	953200000	-9.16
free cash flow	749700000	700300000	7.05
capital expenditure	-116200000	-252900000	54.05
depreciation and amortization	87900000	336500000	-73.88
deferred income tax	0	-55400000	100.00
stock based compensation	30100000	26500000	13.58
accounts payables	109500000	29100000	276.29
inventory	-8900000	-19900000	55.28
acquisitions net	-915600000	-121500000	-653.58
investments in property plant and equipment	-116200000	-252900000	54.05
net cash used for investing activites	-1072200000	-458600000	-133.80
debt repayment	-290800000	-34500000	-742.90
common stock issued	0	0	NaN
common stock repurchased	-39500000	-11300000	-249.56
dividends paid	-99600000	-99300000	-0.30
net cash used provided by financing activities	-458400000	-146000000	-213.97
cash at end of period	519500000	1169300000	-55.57
accounts receivables	-1600000	-86800000	98.16
cash at beginning of period	1165500000	814700000	43.06

Overall Score of Annual Cashflow Statement

0.11 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -646 million in 2023 from 355 million in 2022 representing a change of -282.18%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 866 million in 2023 from 953 million in 2022 representing a change of -9.16%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -116 million in 2023 from -253 million in 2022 representing a change of 54.05%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -55 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 30 million in 2023 from 26 million in 2022 representing a change of 13.58%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 110 million in 2023 from 29 million in 2022 representing a change of 276.29%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -2 in 2023 from -87 million in 2022 representing a change of 98.16%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -100 million in 2023 from -99 million in 2022 representing a change of -0.3%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Free Cash Flow: Free Cash Flow increased to 750 million in 2023 from 700 million in 2022 representing a change of 7.05%. This indicates an increase in cash generated after accounting for capital expenditures.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	466000000	436500000	6.76
free cash flow	406700000	360900000	12.69
capital expenditure	-59300000	-75600000	21.56
depreciation and amortization	185000000	189500000	-2.37
deferred income tax	0	161200000	-100.00
stock based compensation	19000000	16600000	14.46
accounts receivables	-79000000	13300000	-693.98
accounts payables	74000000	27400000	170.07
inventory	2700000	15900000	-83.02
acquisitions net	500000	-1800000	127.78
investments in property plant and equipment	-59300000	-75600000	21.56
net cash used for investing activites	-199100000	-86200000	-130.97
debt repayment	22900000	-211800000	110.81
common stock issued	0	0	NaN
common stock repurchased	-13500000	-24800000	45.56
dividends paid	-99800000	0	NaN
net cash used provided by financing activities	-318200000	-248300000	-28.15
net change in cash	467500000	115000000	306.52
cash at end of period	467500000	528400000	-11.53
cash at beginning of period	0	413400000	-100.00

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 468 million in 2024Q2 from 115 million in 2023Q4 representing a change of 306.52%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 466 million in 2024Q2 from 436 million in 2023Q4 representing a change of 6.76%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 407 million in 2024Q2 from 361 million in 2023Q4 representing a change of 12.69%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -79 million in 2024Q2 from 13 million in 2023Q4 representing a change of -693.98%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -59 million in 2024Q2 from -76 million in 2023Q4 representing a change of 21.56%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 19 million in 2024Q2 from 17 million in 2023Q4 representing a change of 14.46%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 74 million in 2024Q2 from 27 million in 2023Q4 representing a change of 170.07%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -100 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2022 Earnings call transcript
Q2 2022 Earnings call transcript
Q1 2022 Earnings call transcript
Q4 2021 Earnings call transcript
Q3 2021 Earnings call transcript
Q2 2021 Earnings call transcript
Q1 2021 Earnings call transcript
Q4 2020 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	39.97	37.99	5.21
net income per share	7.79	7.81	-0.22
operating cash flow per share	10.47	11.47	-8.76
free cash flow per share	9.06	8.43	7.52
cash per share	6.39	14.45	-55.79
book value per share	46.22	40.16	15.09
tangible book value per share	5.82	7.12	-18.31
shareholders equity per share	46.24	40.17	15.11
interest debt per share	3.93	9.57	-58.90
market cap	8925786343.5	8349665022	6.90
enterprise value	8703486343.5	7951965022	9.45
pe ratio	13.85	12.87	7.60
price to sales ratio	2.7	2.65	2.05
pocfratio	10.31	8.76	17.68
pfcf ratio	11.91	11.92	-0.14
pb ratio	2.33	2.5	-6.73
ptb ratio	2.33	2.5	-6.73
ev to sales	2.63	2.52	4.49
enterprise value over ebitda	7.61	7.03	8.29
ev to operating cash flow	10.05	8.34	20.49
ev to free cash flow	11.61	11.36	2.24
earnings yield	0.07	0.08	-7.06
free cash flow yield	0.08	0.08	0.14
debt to equity	0.08	0.23	-65.39
debt to assets	0.05	0.14	-64.82
net debt to ebitda	-0.19	-0.35	44.70
current ratio	1.17	1.8	-35.00
interest coverage	42.06	39.65	6.08
income quality	1.4	1.61	-12.68
dividend yield	0.01	0.01	-6.17
payout ratio	0.15	0.15	0.96
sales general and administrative to revenue	0.07	0.07	1.03
research and ddevelopement to revenue	0.19	0.14	32.77
intangibles to total assets	0.53	0.49	8.00
capex to operating cash flow	0.13	0.27	-49.42
capex to revenue	0.04	0.08	-56.14
capex to depreciation	1.32	0.75	75.89
stock based compensation to revenue	0.01	0.01	8.43
graham number	90.03	84.0	7.17
roic	0.14	0.18	-22.00
return on tangible assets	0.22	0.23	-4.56
graham net net	-16.35	-5.47	-198.88
working capital	271600000	1062200000	-74.43
tangible asset value	481100000	591500000	-18.66
net current asset value	-600700000	126400000	-575.24
invested capital	4188900000	4388800000	-4.55
average receivables	631900000	598400000	5.60
average payables	709250000	620900000	14.23
average inventory	286800000	251750000	13.92
days sales outstanding	69.69	73.14	-4.72
days payables outstanding	492.93	447.59	10.13
days of inventory on hand	184.99	196.51	-5.86
receivables turnover	5.24	4.99	4.95
payables turnover	0.74	0.82	-9.20
inventory turnover	1.97	1.86	6.22
roe	0.17	0.19	-13.32
capex per share	1.4	3.04	-53.85

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.17 on 2023-12-31 from 0.19 on 2022-12-31, representing a change of -13.32%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Current Ratio: Current Ratio decreased to 1.17 on 2023-12-31 from 1.80 on 2022-12-31, representing a change of -35.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 13.85 on 2023-12-31 from 12.87 on 2022-12-31, representing a change of 7.60%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.08 on 2023-12-31 from 0.23 on 2022-12-31, representing a change of -65.39%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
IPN.PA
calendar year	2024	2023	NaN
revenue per share	21.9	19.25	13.74
net income per share	2.9	5.44	-46.65
operating cash flow per share	5.82	5.28	10.27
free cash flow per share	5.08	4.37	16.40
cash per share	6.07	6.52	-6.98
book value per share	50.57	46.27	9.30
tangible book value per share	6.04	-2.21	373.02
shareholders equity per share	50.58	46.29	9.28
interest debt per share	6.26	5.89	6.35
market cap	9184547825.6	8916774103.9	3.00
enterprise value	9189347825.6	8863874103.9	3.67
pe ratio	9.9	4.96	99.44
price to sales ratio	5.24	5.6	-6.46
pocfratio	19.71	20.43	-3.52
pfcf ratio	22.58	24.71	-8.60
pb ratio	2.27	2.33	-2.64
ptb ratio	2.27	2.33	-2.64
ev to sales	5.25	5.57	-5.85
enterprise value over ebitda	19.08	14.04	35.87
ev to operating cash flow	19.72	20.31	-2.89
ev to free cash flow	22.59	24.56	-8.00
earnings yield	0.03	0.05	-49.86
free cash flow yield	0.04	0.04	9.41
debt to equity	0.12	0.12	-2.56
debt to assets	0.07	0.08	-0.44
net debt to ebitda	0.01	-0.08	111.89
current ratio	1.14	1.17	-2.23
interest coverage	29.16	42.03	-30.63
income quality	2.01	0.97	106.71
dividend yield	0.01	0	NaN
payout ratio	0.43	0	NaN
sales general and administrative to revenue	0.06	0	NaN
research and ddevelopement to revenue	0.18	0.21	-10.76
intangibles to total assets	0.54	0.63	-14.11
capex to operating cash flow	0.13	0.17	-26.53
capex to revenue	0.03	0.05	-28.77
capex to depreciation	0.32	0.4	-19.65
stock based compensation to revenue	0.01	0.01	3.95
graham number	57.45	75.24	-23.65
roic	0.05	0.08	-36.52
return on tangible assets	0.08	0.19	-59.91
graham net net	-16.75	-16.24	-3.15
working capital	234600000	271600000	-13.62
tangible asset value	482900000	-182700000	364.31
net current asset value	-601300000	-600600000	-0.12
invested capital	4392000000	4852800000	-9.50
average receivables	675250000	640350000	5.45
average payables	814500000	759000000	7.31
average inventory	281100000	319750000	-12.09
days sales outstanding	36.95	35.71	3.46
days payables outstanding	243.71	230.42	5.77
days of inventory on hand	77.5	86.48	-10.38
receivables turnover	2.44	2.52	-3.34
payables turnover	0.37	0.39	-5.45
inventory turnover	1.16	1.04	11.59
roe	0.06	0.12	-51.18
capex per share	0.74	0.91	-18.98

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.90 on 2024-06-30 Q2 from 4.96 on 2023-12-31 Q4, representing a change of 99.44%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.12 on 2024-06-30 Q2 from 0.12 on 2023-12-31 Q4, representing a change of -2.56%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.14 on 2024-06-30 Q2 from 1.17 on 2023-12-31 Q4, representing a change of -2.23%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 185.17 which is higher than current price 119.2, indicates the company may be undervalued.